Sudarshan Pharma Industries IPO GMP, Price, Dates & Allotment Details 2023

The Sudarshan Pharma Industries IPO will open on March 9 and close on March 14, 2023. As per the DRHP filed with SEBI, the company intends to raise approximately ₹ 50.10 crore through this public offering, consisting of 6,862,400 shares of face value of ₹ 10 each. Which will be issued at a price of ₹ 71 to ₹ 73 per share.

Incorporated in 2008. Company engaged in the specialties of chemicals and intermediates for pharma, agrochemicals, coatings, paints, adhesives, and various other industries. The company is also into the manufacturing of active pharmaceutical ingredients. Some products it outsources and manufactures at its toll manufacturing facility, and the company is also into specialty chemical imports and exports as well as supplying the same to actual users. As per the clients needs and requirements, the company provides customized specialty chemicals to its own clients in India and abroad regularly. Its specialty chemicals and intermediates have wide application in sectors like pharma, agrochemicals, performance chemicals, resins, paint, food, adhesives, and various other industries.

The company is also involved in contract manufacturing, outsourcing, and supplying generic pharmaceutical formulations and medicines to healthcare institutions, governments, non-governmental organizations, and hospitals.

They operate both in domestic and international markets. Presently, the company is supplying active pharmaceutical ingredients (APIs), intermediate finished dosage formulations (FDFs), and specialty chemicals (SCs) in the domestic market and also exporting to other countries.

Objects of the Issue

The company proposes to utilize the net proceeds of the Fresh Issue towards funding the following objects:

1. Working Capital Requirements
2. General Corporate Purposes.

Financial Highlights (Restated)

Particulars	Period ended on 30th June 2022	FY 2021-22	FY 2020-21
Net Worth	3,192.45	2,977.53	2,250.74
Total Assets	14,703.74	13,752.18	9,926.02
Total Borrowings	4,737.02	3,059.24	2,977.09
Total Revenue	10,587.79	35,755.89	19,372.82
Profit After Tax	225.37	530.37	267.12

Sudarshan Pharma Industries IPO – Details

As per the DRHP filed with SEBI, a total of 68.624 lakh shares will be offered as part of the fresh issue on the BSE SME segment. The face value of the shares is ₹ 10. The market maker would receive 74,400 shares of the offering. While Gretex Corporate Services Pvt Ltd will be the lead manager for the IPO, KFin Technologies Limited will be the registrar. It will be a book-built issue, so there will be a price band rather than a price point, and the actual issue price will be discovered through the building of the book.

Issue Type	Book Built Issue IPO
IPO Price	₹ 71 to ₹ 73 per share
Face Value	₹ 10 per share
Market Lot	1,600 Shares
Issue Size	6,862,400 shares of ₹ 10  (Aggregating up to ₹ 50.10 Crore)
Fresh Issue	6,862,400 shares of ₹ 10  (Aggregating up to ₹ 50.10 Crore)
QIB Shares Offered	Not more than 50% of the Net Issue
NII (HNI) Shares Offered	Not less than 15% of the Net Issue
Retail Shares Offered	Not less than 35% of the Net Issue
Market Maker	GRETEX SHARE BROKING PVT. LTD.
Listing At	BSE SME
Company Promoters	Mr. Hemal Vasantrai Mehta  Mr. Sachin Vasantrai Mehta

GMP – Sudarshan Pharma Industries IPO

Sudarshan Pharma Industries’ IPO GMP, or grey market premium, is available on this page. The IPO GMP is updated on a day-to-day basis during the running period of the IPO, due to which the GMP rates fluctuate and stabilize after some time. GMP rates are not 100% guaranteed. Please click here for GMP details.

Tentative Dates – Sudarshan Pharma Industries IPO

The issue opens for subscription on March 9, 2023, and closes for subscription on March 14, 2023 (both days inclusive). The basis of allotment will be finalized on March 17th, 2023, and the refunds will be initiated on March 20th, 2023. In addition, the demat credits are expected to happen on March 21, 2023, and the stock will list on March 22, 2023, on the BSE SME segment. 

Opening Date	March 9, 2023
Closing Date	March 14, 2023
Basis of Allotment	March 17, 2023
Initiation of Refunds	March 20, 2023
Credit of shares to Demat A/c	March 21, 2023
Listing Date	March 22, 2023

Lot Size – Sudarshan Pharma Industries IPO

The lot size of the Sudarshan Pharma Industries IPO is 1,600 shares. A retail-individual investor can apply for up to  lots, i.e. 1,600 shares of  ₹ 116,800.

Applications	Lots	Shares	Amount
Retail (Minimum)	1	1,600	₹ 116,800
Retail (Maximum)	1	1,600	₹ 116,800
HNI (Minimum)	2	3,200	₹ 233,600

Promoters Holdings – Sudarshan Pharma Industries IPO

Pre-issue Shares Holdings	80.28%
Post-issue Shares Holdings	–

SWOT Analysis – Sudarshan Pharma Industries IPO

STRENGTHS	WEAKNESSES
1. Quality & Innovative product gives a market edge for most of the suppliers.  2. Reliable Contact Manufacturing & sourcing of Formulation, API and drugs.  3. Rising Demand for API and Formulation.  4. Competitive edge in terms of quality and bidding.  5. Good marketing & distribution network.  6. Vast Experience of Promoters in the Field.	1. Dependent upon growth in the Pharma and API industry & competition from China and International suppliers.  2. The requirement of Finance to cater to at a national level. Limited market share & presence in a few segments.  3. Customers supply door to door on a national level.    4. Competitors can offer similar products quickly.
OPPORTUNITIES	THREATS
1. Growing acceptance by consumers of new and innovative formulation and awareness.  2. Rising in demand for products in emerging areas and exports. 3. Growing E-commerce and Online sale enables it to cater on a national level easily.  4. Huge demand for the development of special products suitable for Pharma and API.	1. Changes in government policies.  2. Fluctuations in raw material prices.  3. Change of behavior of consumer demand.  4. Increase in Input cost can cause upward pricing.  5. Too many players entering and exiting the market.

Miscellaneous Information

Download Prospectus (PDF)	IPO DRHP
Company Contact Information	Sudarshan Pharma Industries Ltd 301,3rd Floor, Aura Biplex, Above Kalyan Jewellers S. V. Road, Borivali (West) Mumbai – 400092 Phone: 022- 42221111 Email: compliance@sudarshanpharma.com Website: http://www.sudarshanpharma.com/
IPO Registrar	KFin Technologies Limited Phone: 04067162222, 04079611000 Email: einward.ris@kfintech.com Website: https://karisma.kfintech.com/
IPO Lead Manager(s)	Gretex Corporate Services Pvt Ltd

FAQ’s

Click here for more FAQs.